Mendus AB (IMMUN)

Stockholm
2.24
-0.03(-1.32%)
  • Volume:
    67,720
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    2.20 - 2.31
Earnings results expected in 10 days

Mendus AB will announce its quarterly financial results in 10 days. Traders should take this into account as the share price often fluctuates around this time period.

IMMUN Overview

Prev. Close
2.27
Day's Range
2.2-2.31
Revenue
1.79M
Open
2.31
52 wk Range
1.75-3.7
EPS
-0.647
Volume
67,720
Market Cap
446.66M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
178,188
P/E Ratio
-
Beta
-
1-Year Change
-28.28%
Shares Outstanding
199,400,599
Next Earnings Date
17 Feb 2023
What is your sentiment on Mendus AB?
or
Market is currently closed. Voting is open during market hours.

Mendus AB Company Profile

Mendus AB Company Profile

  • Type:Equity
  • Market:Sweden
  • ISIN:SE0005003654
  • S/N:199400599

Mendus AB (publ), formerly Immunicum AB, is a Sweden-based company that is engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The Company develops off-the-shelf, cell-based products that are immunogenic based on underlying allogeneic dendritic cell biology and which have the potential to activate the patient’s own immune system against cancer. The Company’s programs ilixadencel and DCP-001 are derived from healthy donor material and from Company's DCOne cell line, respectively. The Company develops ilixadencel to address the tumor burden of established tumors via intratumoral immune priming and DCP-001 as a cancer relapse vaccine, aimed at the reduction of tumor recurrence following initial treatment. Mendus has offices in Sweden and the Netherlands.

Read More

Analyst Price Target

Average6.75 (+201.34% Upside)
High7.00
Low6.50
Price2.24
No. of Analysts2
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellSell
SummarySellStrong SellStrong SellStrong SellStrong Sell